Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J0570 |
Short Description | Buprenorphine implant 74.2mg |
Long Description | Buprenorphine implant, 74.2 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2017-01-01 |
Date Added | 2017-01-01 |
Drug Details
-
Buprenorphine extended-release injection is used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers) in people who have received buccal or sublingual buprenorphine for at least 7 days. Buprenorphine extended-release injection is in a class of medications called opiate partial agonists. It works to prevent withdrawal symptoms when someone stops taking opioid drugs by producing similar effects to these drugs.